SC Filed 2023-01-06 Event — SEC 0001193125-23-003571 →

Versant Venture Capital V, L.P. → Repare Therapeutics Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

10 13D/G filings on this issuer

9 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $133K

Point72 Asset Mgmt

Other 13D/G Filings on Repare Therapeutics Inc.

Filed	Form	Filer	Stake	Shares
2025-11-24	SCHEDULE	BIOTECHNOLOGY VALUE FUND L P	24.00%	10,333,600	view →
2025-01-31	SCHEDULE	MPM BioVentures 2014, L.P.	4.60%	1,941,242	view →
2025-01-15	SCHEDULE	MPM BioVentures 2014, L.P.	5.10%	2,149,415	view →
2025-01-06	SCHEDULE	MPM BioVentures 2014, L.P.	6.30%	2,658,532	view →
2021-08-16	SC	Versant Venture Capital V, L.P.	—	—	view →
2021-07-21	SC	MPM BioVentures 2014, L.P.	—	—	view →
2021-05-25	SC	MPM BioVentures 2014, L.P.	—	—	view →
2021-03-23	SC	MPM BioVentures 2014, L.P.	—	—	view →
2021-01-25	SC	Versant Venture Capital V, L.P.	—	—	view →

Other Filings by Versant Venture Capital V, L.P.

Filed	Form	Issuer	Stake	Shares
2021-08-16	SC	Repare Therapeutics Inc.	—	—	view →
2021-01-25	SC	Repare Therapeutics Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →